CTRI/2016/10/007346已完成3 期
10mg versus 5mg initiation dose of Warfarin to achieve adequate anticoagulation in the treatment of acute deep vein thrombosis - A Randomized Control Trial
Fluid Research Grant Christian Medical College Vellore0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients, 18 years or older, with acute deep vein thrombosis being started on oral anticoagulation therapy by the division of surgery who consent to participation in the trial
排除标准
- •1.Weight <40kgs
- •2.Underlying liver, renal disease
- •3.Recent treatment with any anticoagulants (within the preceding 5 days), Baseline INR >1.4
- •4.Pre-existing bleeding diatheses.
- •5.Diagnosed pulmonary embolism
- •6.Special patients eg pregnancy, children
- •7.Non consent
研究者
相似试验
进行中（未招募）
3 期
The efficacy of different warfarin starting doses (3 mg versus 5 mg) and the corresponding dosing schedule in patients diagnosed with deep vein thrombosisThe efficacy of different warfarin initiating dose in patients diagnosed with venous thromboembolismwarfarin,initiating dose,efficacy,venous thromboembolismTCTR20180328002Faculty of Medicine Siriraj Hospital, Mahidol University56
尚未招募
不适用
Bioequivalence study of Warfarin 5 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N18Tabriz University of Medical Sciences24
招募中
4 期
Outcomes of Warfarin and Rivaroxaban (Xalerban) consumption in patients with Atrial fibrillatioIRCT20170530034232N2Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences330
尚未招募
不适用
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa universityJPRN-UMIN000020069Division of Cardiology, Department of Medicine,Showa university100
招募中
2 期
Effect of warfarin and rivaroxaban in coronary endartherectomyIRCT20181124041746N1Kermanshah University of Medical Sciences120